While the lack of consensus among DNMT levels across anxiety models make these enzymes a harder treatment target group, possible anxiety treatments include more specific HDAC inhibitors, since this class of drugs have been shown to encourage BDNF expression and neurogenesis, a phenomenon that may bolster CBT and fear memory extinction when treating ADs. This evidence concerns the gene DNMT1 and Anxiety.